Yolanda Falcón García

UNIRISCO Galicia (UNIRISCO) is an independent Spanish venture capital firm which was formed in 2000 as part of a University of Santiago de Compostela initiative to promote the creation of companies making use of technology research emanating from the University of Santiago and the University of Vigo. Based in Santiago de Compostela, UNIRISCO facilitates direct contact between major R&D centres in Galicia, allowing access to the university research groups and their scientific production skills. They also provide investee companies with consultancy services and access to their network of partners.

Algenex SL develops and manufactures recombinant proteins. It specializes in the baculovirus vector-based innovative technologies to manufacture recombinant proteins used to produce vaccines, diagnostic reagents and therapeutic molecules. The company was founded by Jose Angel Martinez Escribano and Covadonga Alonso on January 19, 2005 and is headquartered in Pozuelo de Alarcon, Spain.

Immunostep SL develops and manufactures cell reagents. The firms manufacture and commercialization of cell culture reagents for use in flow cytometry diagnosis and clinical research. Its services include polyclonal development, contract services, price list service, monoclonal development, chicken polyclonal development, rabbit polyclonal development. The company was founded by Ricardo Jara Acevedo, Jose Claros Parra and Alfredo Conde Alonso in September 2001 and is headquartered in Salamanca, Spain.

Biocontrol Technologies. SL develops and produces microorganisms as pest control agents. The firm offers T-34 Biocontrol product. It services include analysis of pathogen populations, specific seminars for formers and advisers in different fields to improve plant growth. The company was founded by Francesc Peremiquel Lluch in 2004 and is headquartered in Barcelona, Spain.